CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE
- PMID: 20648231
- PMCID: PMC2905823
- DOI: 10.1016/j.ddmec.2009.02.001
CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE
Abstract
Carnitines are involved in mitochondrial transport of fatty acids and are of critical importance for maintaining normal mitochondrial function. This review summarizes recent experimental and clinical studies showing that mitochondrial dysfunction secondary to a disruption of carnitine homeostasis may play a role in decreased NO signaling and the development of endothelial dysfunction. Future challenges include development of agents that can positively modulate L-carnitine homeostasis which may have high therapeutic potential.
Figures
References
-
- Bremer J. Carnitine--metabolism and functions. Physiol Rev. 1983;63(4):1420–1480. - PubMed
-
- Sahajwalla CG, et al. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J Pharm Sci. 1995;84(5):627–633. - PubMed
-
- Tamai I, et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem. 1998;273(32):20378–20382. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources